EMMA, which went public via a reverse merger a few days ago, received a Nasdaq delisting notice (to be appealed, of course): https://finance.yahoo.com/news/emmaus-life-sciences-completes-merger-225100145.html https://www.prnewswire.com/news-releases/emmaus-life-sciences-receives-notice-of-nasdaq-delisting-following-merger-with-mynd-analytics-300888905.html